HU9502994D0 - Active substance-containing plaster - Google Patents

Active substance-containing plaster

Info

Publication number
HU9502994D0
HU9502994D0 HU9502994A HU9502994A HU9502994D0 HU 9502994 D0 HU9502994 D0 HU 9502994D0 HU 9502994 A HU9502994 A HU 9502994A HU 9502994 A HU9502994 A HU 9502994A HU 9502994 D0 HU9502994 D0 HU 9502994D0
Authority
HU
Hungary
Prior art keywords
active substance
containing plaster
plaster
vitamin
deriv
Prior art date
Application number
HU9502994A
Other languages
English (en)
Other versions
HU223045B1 (hu
HUT73668A (en
Inventor
Wilfried Fischer
Karin Klokkers
Original Assignee
Hexal Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19934339400 external-priority patent/DE4339400A1/de
Application filed by Hexal Ag filed Critical Hexal Ag
Publication of HU9502994D0 publication Critical patent/HU9502994D0/hu
Publication of HUT73668A publication Critical patent/HUT73668A/hu
Publication of HU223045B1 publication Critical patent/HU223045B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Laminated Bodies (AREA)
HU9502994A 1993-04-20 1994-04-20 Ösztrogén vagy progesztagén hormont tartalmazó tapasz HU223045B1 (hu)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4312818 1993-04-20
DE19934339400 DE4339400A1 (de) 1993-11-18 1993-11-18 Wirkstoffpflaster
PCT/EP1994/001231 WO1994023707A1 (de) 1993-04-20 1994-04-20 Wirkstoffplaster

Publications (3)

Publication Number Publication Date
HU9502994D0 true HU9502994D0 (en) 1995-12-28
HUT73668A HUT73668A (en) 1996-09-30
HU223045B1 HU223045B1 (hu) 2004-03-01

Family

ID=25925074

Family Applications (2)

Application Number Title Priority Date Filing Date
HU0301253A HU223042B1 (hu) 1993-04-20 1994-04-20 Parkinson-kór kezelésére alkalmas hatóanyagot tartalmazó tapasz
HU9502994A HU223045B1 (hu) 1993-04-20 1994-04-20 Ösztrogén vagy progesztagén hormont tartalmazó tapasz

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HU0301253A HU223042B1 (hu) 1993-04-20 1994-04-20 Parkinson-kór kezelésére alkalmas hatóanyagot tartalmazó tapasz

Country Status (14)

Country Link
US (2) US5683711A (hu)
EP (2) EP0695177B1 (hu)
JP (1) JP3489831B2 (hu)
AT (2) ATE163262T1 (hu)
AU (1) AU678237B2 (hu)
CA (1) CA2161004C (hu)
DE (2) DE59405277D1 (hu)
DK (2) DK0695177T3 (hu)
ES (2) ES2164286T3 (hu)
FI (1) FI114782B (hu)
HU (2) HU223042B1 (hu)
NO (1) NO311829B1 (hu)
PT (1) PT813865E (hu)
WO (1) WO1994023707A1 (hu)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4429667C2 (de) * 1994-08-20 1996-07-11 Lohmann Therapie Syst Lts Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
DE19517145C2 (de) * 1995-05-10 2000-02-24 Hexal Pharmaforschung Gmbh Transdermales therapeutisches System (TTS) zur Verabreichung von Testosteron
NZ309980A (en) * 1995-06-07 2001-06-29 Noven Pharma Transdermal composition containing a blend of one or more polymers, one or more drugs that has a low molecular weight and is liquid at room temperature
US6316022B1 (en) * 1995-06-07 2001-11-13 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
DE19533089C1 (de) 1995-09-07 1997-05-22 Hexal Ag Tacrin-Pflaster
DE19642043A1 (de) * 1995-10-23 1997-04-24 Hexal Ag Transdermales therapeutisches System (TTS) für die Verabreichung von Wirkstoffen zur Behandlung von Drogenabhängigkeit oder Drogensucht
DE19548332A1 (de) * 1995-12-22 1997-07-10 Rotta Res Bv Hormonpflaster
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US20020012694A1 (en) * 1997-09-17 2002-01-31 Alfred J. Moo-Young Transdermal administration of ment
US6767902B2 (en) 1997-09-17 2004-07-27 The Population Council, Inc. Androgen as a male contraceptive and non-contraceptive androgen replacement
WO1999026571A1 (en) 1997-11-25 1999-06-03 Theratech, Inc. Transdermal delivery devices containing polydiorganosiloxane polymers to regulate adhesive properties
DE19814257A1 (de) 1998-03-31 1999-10-07 Asta Medica Ag Brauseformulierungen
DE19828273B4 (de) * 1998-06-25 2005-02-24 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
US6475514B1 (en) 1998-12-03 2002-11-05 Andrew Blitzer Athletic patch
DE19859910C2 (de) * 1998-12-23 2001-03-22 Ratiopharm Gmbh Orales Arzneimittel
US7026290B1 (en) 1998-12-30 2006-04-11 Dexcel Ltd. Dispersible concentrate for the delivery of cyclosprin
US6417227B1 (en) 1999-04-28 2002-07-09 Cg And Associates Methods of delivery of cetyl myristoleate
US6358939B1 (en) 1999-12-21 2002-03-19 Northern Lights Pharmaceuticals, Llc Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease
US6989377B2 (en) 1999-12-21 2006-01-24 Wisconsin Alumni Research Foundation Treating vitamin D responsive diseases
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
US7235397B1 (en) * 2000-04-14 2007-06-26 Gensys, Inc. Methods and compositions for culturing spirochete and treating spirochetal diseases
DE10066158B4 (de) * 2000-08-24 2007-08-09 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung des Restless-Legs-Syndroms
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
US20020119187A1 (en) * 2000-09-29 2002-08-29 Cantor Adam S. Composition for the transdermal delivery of fentanyl
US20020198215A1 (en) * 2000-10-23 2002-12-26 Lino Tavares Terazosin transdermal device and methods
DE10141651B4 (de) * 2001-08-24 2007-02-15 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung
DE10141652B4 (de) * 2001-08-24 2011-04-07 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
US20040258739A1 (en) * 2001-09-04 2004-12-23 Rudy Susilo Plaster for the treatment of dysfunctions and disorders of nails
KR20110120358A (ko) * 2002-06-10 2011-11-03 유로-셀티크 소시에떼 아노뉨 경피 전달 장치에 포함된 활성 성분의 오용을 방지하는 경피 전달 장치의 처리 시스템
MXPA05008366A (es) * 2003-02-07 2005-11-04 Lohmann Therapie Syst Lts Sistema terapeutico transdermico adecuado para la aplicacion de calor para promover la penetracion de sustancias activas y el uso del mismo.
CZ295826B6 (cs) * 2003-04-28 2005-11-16 Ústav Makromolekulární Chemie Av Čr Materiál pro krytí ran obsahující lapače radikálů
GEP20084561B (en) * 2003-10-28 2008-12-10 Noven Pharma System and method for controlled drug release and transdermal drug delivery device
US20050096311A1 (en) * 2003-10-30 2005-05-05 Cns Response Compositions and methods for treatment of nervous system disorders
DE102004059880A1 (de) * 2004-12-10 2006-06-14 Grünenthal GmbH Stabiles, hormonhaltiges (Zwischen-)Produkt
WO2006082728A1 (ja) * 2005-02-04 2006-08-10 Hisamitsu Pharmaceutical Co., Inc. 経皮吸収貼付剤
US20070018059A1 (en) * 2005-07-25 2007-01-25 Woodcock John E Apparatus for holding a container at an angle
CA2674681C (en) * 2007-01-11 2014-12-02 Drossapharm Ag Medically active plaster for releasing an active compound that is liquid at room temperature
US8513323B2 (en) * 2007-06-22 2013-08-20 Kimbery-Clark Worldwide, Inc. Multifunctional silicone blends
ES2528650T3 (es) 2010-11-17 2015-02-11 Hexal Ag Sistema terapéutico transdérmico que comprende buprenorfina
JP6893086B2 (ja) 2013-03-13 2021-06-23 エーブリー デニソン コーポレイション 接着特性の向上

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7711916A (nl) * 1977-10-29 1979-05-02 Akzo Nv Werkwijze ter bereiding van sterk geconcen- treerde farmaceutische preparaten van steroiden.
US4439432A (en) * 1982-03-22 1984-03-27 Peat Raymond F Treatment of progesterone deficiency and related conditions with a stable composition of progesterone and tocopherols
JPS59184121A (ja) * 1983-03-31 1984-10-19 Nitto Electric Ind Co Ltd アクリル系膏体
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
CH674618A5 (hu) * 1987-04-02 1990-06-29 Ciba Geigy Ag
US5300291A (en) * 1988-03-04 1994-04-05 Noven Pharmaceuticals, Inc. Method and device for the release of drugs to the skin
GB8807504D0 (en) * 1988-03-29 1988-05-05 Sandoz Ltd Improvements in/relating to organic compounds
JP2857882B2 (ja) * 1988-11-02 1999-02-17 富山化学工業株式会社 ピロキシカムのプラスター剤
DE3902013A1 (de) * 1989-01-25 1990-09-20 Knoll Ag Pflaster zur transdermalen anwendung
JP2875611B2 (ja) * 1990-08-29 1999-03-31 エーザイ株式会社 ケイ酸カルシウム含有外用剤
GB9021674D0 (en) * 1990-10-05 1990-11-21 Ethical Pharma Ltd Transdermal device
DE4116912A1 (de) * 1991-05-18 1992-11-26 Schering Ag Mittel zur transdermalen applikation enthaltend ergolin-derivate
AU658681B2 (en) * 1991-10-23 1995-04-27 Block Drug Company Inc., The Penetration enhancement of topically applied formulations
DE4237453C1 (hu) * 1992-11-06 1993-08-19 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De

Also Published As

Publication number Publication date
EP0695177B1 (de) 1998-02-18
AU6569694A (en) 1994-11-08
HU223045B1 (hu) 2004-03-01
DE59405277D1 (de) 1998-03-26
CA2161004C (en) 2004-10-26
JP3489831B2 (ja) 2004-01-26
NO954186D0 (no) 1995-10-19
EP0695177A1 (de) 1996-02-07
EP0813865B1 (de) 2001-09-19
CA2161004A1 (en) 1994-10-27
US5683711A (en) 1997-11-04
JPH09501398A (ja) 1997-02-10
ATE163262T1 (de) 1998-03-15
HUT73668A (en) 1996-09-30
NO311829B1 (no) 2002-02-04
HU0301253D0 (en) 2003-07-28
FI114782B (fi) 2004-12-31
HU223042B1 (hu) 2004-03-01
US5830505A (en) 1998-11-03
ES2115231T3 (es) 1998-06-16
NO954186L (no) 1995-10-19
FI954989A (fi) 1995-10-19
ES2164286T3 (es) 2002-02-16
AU678237B2 (en) 1997-05-22
FI954989A0 (fi) 1995-10-19
DE59409873D1 (de) 2001-10-25
EP0813865A1 (de) 1997-12-29
ATE205706T1 (de) 2001-10-15
PT813865E (pt) 2002-02-28
DK0695177T3 (da) 1998-09-28
WO1994023707A1 (de) 1994-10-27
DK0813865T3 (da) 2001-11-19

Similar Documents

Publication Publication Date Title
HU9502994D0 (en) Active substance-containing plaster
EP0595133A3 (de) Prodrugs, ihre Herstellung und Verwendung als Arzneimittel
DE69311556D1 (de) Inhalationspulver enthaltend antistatisches hilfsmittel
AU6657994A (en) Solubilizing agent and external preparation containing the same
GB2220350B (en) Delayed release formulations
AU6147190A (en) An active matrix reflective projection system
EP1310244A3 (en) Compositions comprising an anticancer agent and a polyether block copolymer
AU3619295A (en) Antiinflammatory agent for external use
AU3520289A (en) Surface active agents based on poly (1-phenyl ethyl) phenols
AU8121391A (en) Self-sticking matrix system for the sustained transcutaneous release of piribedil
CA2094424A1 (en) Method of treating osteoporosis with 1.alpha.,24(r)-dihydroxy-22(e)-dehydro-vitamin d3
IL118532A0 (en) Moisture-cure urethane adhesive containing gamma-butyrolactone
AU6875691A (en) Insecticide compositions, processes and devices
AU664101B2 (en) Novel phospholipid derivatives
EP0401262A4 (en) 24r-scymnol, and preparation and use thereof
AU6523090A (en) Protection vaccine against swine hemophilosis
AU3808493A (en) Biologically active N-acylprolyldipeptides having antiamnestic, antihypoxic and anorexigenic effects
AU3275889A (en) Bicyclo and azobicyclo-(1,2,3-benzotri-) and (1,3-benzodi-) azine derivatives

Legal Events

Date Code Title Description
HFG4 Patent granted, date of granting

Effective date: 20031204

MM4A Lapse of definitive patent protection due to non-payment of fees
NF4A Restoration of patent protection